Lung Fibrosis is Ameliorated by Pirfenidone Fed in Diet After the Second Dose In A Three-Dose Bleomycin-Hamster Model
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis Ltd in Experimental Lung Research
- Vol. 24 (1), 119-133
- https://doi.org/10.3109/01902149809046058
Abstract
Interstitial lung fibrosis (ILF) is a life-threatening disease which has no known drug for prevention and cure. In the present study, we evaluated the antifibrotic potential of pirfenidone (PD) (5-methyl-1-phenyl-2-(1H)-pyridone) in a three-dose bleomycin (BL)-hamster model of lung fibrosis. Hamsters were intratracheally (IT) instilled with three consecutive doses of bleomycin sulfate (2.5 U/kg/5mL, 2.0 U/kg/5mL, 1.5 U/kg/3.75mL) or an equivalent volume of saline at weekly intervals. Hamsters were fed a diet after the second dose of BL containing 0.5% PD and hamsters in the control groups were fed the same diet without the drug. The four groups were saline-instilled fed control diet (SCD); saline-instilled fed the same diet containing PD (SPD); BL-instilled fed control diet (BCD); and BL-instilled fed the diet containing PD (BPD). Hamsters were sacrificed at 28 days after IT instillation of last dose of saline or BL and their lungs processed for various assays. Lung hydroxyproline, an index of fibrosis, in SCD, SPD, BCD and BPD were 830, 804, 1609, 1235 μg/lung, respectively. Lung prolyl hydroxylase activities in the SPD, BCD and BPD groups were 103%, 313%, 157% of the control SCD group (5.99 ± 104 dpm/lung/30 rain) respectively. Malondialdehyde equivalent levels and superoxide dismutase activity in the corresponding groups were 99, 79, 240 and 145 nmoles/lung and 412, 433, 538 and 410 units/lung respectively. Lung myeloperoxidase activities in the corresponding groups were 56%, 179%, and 116% of the control group (0.44 units/lung). It is concluded that PD is a novel antifibrotic drug that has therapeutic potential in arresting the progression of an ongoing fibrotic process in the lung.Keywords
This publication has 21 references indexed in Scilit:
- Amelioration of Bleomycin-Induced Lung Fibrosis by Treatment with the Platelet Activating Factor Receptor Antagonist Web 2086 in HamstersExperimental Lung Research, 1995
- Development of a bleomycin hamster model of subchronic lung fibrosisPathology, 1992
- Liver contains heparin-binding growth factors as the major growth factor for cultured fibroblastsHepatology, 1991
- Molecular Biology of Prolyl 4-HydroxylaseAnnals of the New York Academy of Sciences, 1990
- Tissue Destruction by NeutrophilsNew England Journal of Medicine, 1989
- Analysis of Bronchoalveolar Lavage Fluid from Bleomycin-Induced Pulmonary Fibrosis in HamstersToxicologic Pathology, 1986
- Effects of intratracheal administration of bleomycin on GSH-shuttle enzymes, catalase, lipid peroxidation, and collagen content in the lungs of hamstersToxicology and Applied Pharmacology, 1983
- On the mechanism of hydrogen peroxide-, superoxide-, and ultraviolet light-induced DNA cleavages of inactive bleomycin-iron(III) complexBiochemical and Biophysical Research Communications, 1982
- Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.Circulation, 1982
- The production of hydroxyl radical by bleomycin and iron (II)FEBS Letters, 1979